These trials completed more than 12 months ago and should have reported results.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Completed, report not yet due 2018-004269-14 Loss of RESponse to Ustekinumab treated by dose Escalation Verlies van respons op ustekinumab behandeld via dosis escalatie Perte de réponse à l’ustékinumab traitée par augmentation de la dose. 2024-09-25 not-yet-due
Other 2021-000345-41 An Open-Label Extension and long-term efficacy and safety monitoring study of patients with Crohn’s disease previously included in the loss of RESponse to Ustekinumab treated by dose Escalation study ... not-yet-due
Completed, report not yet due 2022-001683-10 ChAracterizing the Remission status in patients with Ulcerative Colitis treated by 5-ASA Het karakteriseren van de remissie status bij patiënten met ulceratieve colitis, behandeld met 5-ASA Cara... 2024-02-01 not-yet-due